2QG.F QUANTUM GENOMICS EO -40

Healthcare Biotechnology Frankfurt Exchange
0.0611 EUR
Close of Oct 5, 2026
0.0680 0.0680
Market cap
EUR 4.26M
P/E
-
P/B
0.00x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is 2QG.F undervalued?

Graham number

The Graham number of QUANTUM GENOMICS EO -40 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

QUANTUM GENOMICS EO -40 fundamental analysis

No fundamental analysis for QUANTUM GENOMICS EO -40 yet.

QUANTUM GENOMICS EO -40 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About QUANTUM GENOMICS EO -40

Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

Full company profile